In France, the share of corresponding/leading authors in scientific publications in Endocrinology, Diabetes, and Metabolism is forecasted to show a slightly declining trend over the next five years, decreasing from 89.77% in 2024 to 89.15% in 2028. Despite the decline, these figures remain high, indicating a strong presence of French authorship in this domain. The year-on-year variation shows a consistent reduction, with an average annual decrease measured over five years contributing to the industry insights. The trend sets a steady but modest decline in author share, pointing towards a slowly diversifying authorship landscape.

Future trends to watch for include:

Increased collaboration with international researchers, which may further impact the share of French-leading authorship.
The potential rise of early-career researchers taking leading roles, affected by shifts in scientific policy and funding.
Technological advancements in research methodologies that facilitate broader co-authorship networks.